Immucell (ICCC) Long-Term Deferred Tax (2010 - 2025)

Immucell (ICCC) has reported Long-Term Deferred Tax for 15 consecutive years, with $4.9 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $4.9 million; the trailing twelve-month figure through Dec 2025 stood at $4.9 million (changed N/A YoY), and the FY2025 full-year result was $4.9 million, changed N/A from the prior year.
• Long-Term Deferred Tax grew to $4.9 million in Q4 2025 per ICCC's latest filing, from $3.7 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $4.9 million in Q4 2025 and bottomed at $3.1 million in Q4 2021.
• Historically, Long-Term Deferred Tax has averaged $3.8 million across 4 years, with a median of $3.5 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Long-Term Deferred Tax rose 0.63% in 2021, then increased 14.46% in 2023.
• Over 4 years, Long-Term Deferred Tax stood at $3.1 million in 2021, then climbed by 5.3% to $3.3 million in 2022, then rose by 14.46% to $3.7 million in 2023, then soared by 32.1% to $4.9 million in 2025.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.9 million, $3.7 million, and $3.3 million for Q4 2025, Q4 2023, and Q4 2022 respectively.